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Abstract 
Recent work using micro-Fourier transform infrared (µFTIR) imaging has revealed that a lipid-rich 
layer surrounds many plaques in post-mortem Alzheimer’s brain. However, the origin of this lipid 
layer is not known, nor is its role in the pathogenesis of Alzheimer’s disease (AD). Here, we studied 
the biochemistry of plaques in situ using a model of AD. We combined FTIR, Raman and 
immunofluorescence images, showing that astrocyte processes co-localise with the lipid-ring 
surrounding many plaques. We used µFTIR imaging to rapidly measure chemical signatures of 
plaques over large fields of view, and selected plaques for higher resolution analysis with Raman. 
Raman maps showed similar lipid-rings and dense protein cores as in FTIR images, but also revealed 
cell bodies. We confirmed the presence of plaques using amylo-glo staining, and measured 
astrocytes using immunohistochemistry, revealing astrocyte co-localisation with lipid-rings. This 
work is important because it correlates biochemically changes surrounding the plaque with the 
biological process of astrogliosis. 
 
 
Introduction 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of 
dementia worldwide. There are currently 47 million affected people, a number that is predicted to 
double every 20 years 1, hence posing a significant burden in healthcare management of an ageing 
population. Amyloidopathy is a major hallmark of AD and consists in the abnormal accumulation in 
the brain parenchyma of the amyloid-β peptide (Aβ), an aggregation-prone protein fragment of 40–
42 amino acids produced by the cleavage of amyloid precursor protein (APP). The monomer form of 
the Aβ peptide is thought to physiologically exist as a soluble molecule in the brain; in some cases, 
Aβ monomers can progressively aggregate forming oligomers until they eventually precipitate into 
insoluble fibrils and finally nucleating to form insoluble plaques 2, 3. Soluble oligomers have 
increasingly being recognised as the neurotoxic form of Aβ that can also be found, as a marker of the 
disease, in blood and cerebrospinal fluid 4-6. The Aβ peptide is the main but not the only component 
of amyloid plaques. The oligomeric composition of the deposits determines the biological effect and 
plausibly the clinical outcome of β-amyloidosis 
7
. Neurotoxicity seems to arise from early 
accumulation of soluble oligomeric species, rather than insoluble fibrils (with prevalent antiparallel 
β-strands 8) or larger plaque formations. 
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The lack of a diagnostic tool for AD in vivo has prompted early attempts of applying vibrational 
spectroscopy techniques to investigate the molecularity and structure of Aβ plaques in the brain of 
both humans and mouse models of AD 9. Intriguingly, these studies have revealed that many plaques 
contain a lipid-rich layer surrounding the plaque. Dense core plaques in a (TgCRND8) transgenic 
mouse brain are composed of intermolecular β-sheet structures of the Aβ peptide, with significant 
increase in lipids around the core 
10
. Though the origin of this lipid layer has been the focus of 
several studies, including some based on multiphoton microscopy, a definitive hypothesis and 
mechanism of whole plaque formation is still lacking. 
 
Significant advances in µFTIR spectroscopic imaging of AD brain have been brought about by Gough 
and co-workers, showing that it is possible to achieve enhanced spatial resolution in focal plane 
array (FPA) detection of plaques using synchrotron light source 10-12 or high magnification optics 13. 
µFTIR imaging has also been applied to probe early conformational changes of Aβ and APP in AD 
mouse brain (Tg19959) that precede plaque formation and localize to synaptic terminals 14. Previous 
work using Raman microscopy 9, 15 has focused on the detection and chemical characterization of Aβ 
deposits, but there is still lack of a combined use of Raman and FTIR imaging in order to obtain 
detailed information about the structure and chemical composition of plaques within the brain. 
 
An in-depth investigation of the molecular species involved in the mechanism of Aβ plaque 
formation is the first step to unravel the pathophysiology of this complex disease. The aim of this 
work was to investigate the chemical and structural character associated with the distribution of 
specific compounds within amyloid plaques. Although some hypotheses have previously been made, 
no definitive conclusion around the origin of the lipid-rich ring surrounding the plaque core has yet 
been made. We clarified this for the first time in the present work using chemical imaging and 
correlative immunofluorescence imaging of plaques. 
 
In this work, we used a TASTPM transgenic mouse model of AD characterized by Aβ overexpression. 
TASTPM mice carry a double mutation on the APP and one single mutation on the presenilin-1 gene 
resulting in severe accumulation of amyloid plaques and cognitive impairment by the sixth month of 
age 
16, 17
. Using fixed brain histological sections obtained from TASTPM mice we analysed the Aβ 
deposits within the hippocampus, a brain area that is involved in memory encoding and is severely 
affected in AD. Here, we provide evidence that plaque-surrounding astrocytic processes correlate 
with the presence of elevated lipid signals in the region surrounding the plaque core. 
 
 
Results 
 
µFTIR and immunofluorescence. Figure 1a shows a photomicrograph of a transgenic (TG) mouse 
brain section, whereby the CA1 subfield of the hippocampus is easily recognizable because of the 
shell-shaped curvature of the tissue. Amyloid plaques can be visually identified as dark spots under 
white light due to light scattering. 
Micro-transmission FTIR images from this location are presented in figure 1b–f. Each chemical image 
represents a plot of the integrated absorbance of a specific band in the IR spectrum across the area 
imaged by the focal plane array (FPA) detector. 
 
Page 2 of 13Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
A
na
ly
st
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
04
 D
ec
em
be
r 2
01
7.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f R
ea
di
ng
 o
n 
04
/1
2/
20
17
 2
2:
20
:2
5.
 
View Article Online
DOI: 10.1039/C7AN01747B
 
 
 
Figure 1. (Top panel) Visible and µFTIR images of a section of transgenic mouse brain containing the hippocampus. (a) 
Photomicrograph. Acronyms, which identify specific regions of the hippocampal CA1 region, are defined in the text. The 
FTIR images refer to the distribution of the integrated absorbance of (b) lipid ν(C=O)ester (1761–1722 cm
–1
), (c) ν(CH) 
(3003–2805 cm
–1
), (d) amide I (1716–1595 cm
–1
), (e) amide II (1593–1483 cm
–1
), and (f) intermolecular β-sheet structure 
(1640–1620 cm
–1
 with baseline at 1716–1595 cm
–1
). (Bottom panel) Spectra, visible and µFTIR images of an amyloid plaque 
extracted from the same measurement. The FTIR images refer to the distribution of the integrated absorbance of (k) amide 
II and (l) lipid ν(C=O)ester bands. The lipid-ring can be clearly seen in (l). Cursors indicate the same pixel in correspondence 
of the plaque core. Black dots in (k) indicate the pixels from which FTIR spectra were selected along a horizontal line from 
the core through to the margin of the plaque. Spectra are colour coded to match the colours in image (k). (g) Main 
absorption bands are assigned to NH stretching (amide A and B; 3600–3000 cm
–1
), CH stretching (3000–2800 cm
–1
), lipid 
ν(C=O)ester (1761–1722 cm
–1
), amide I (1718–1600 cm
–1
), amide II (1590–1480 cm
–1
), phosphate and amide III (1270–1180 
(a) 
SR 
(b) 
SLM 
(c) 
(h) 
(d) 
(i) 
(j) (k) 
(g) 
(e) 
SO 
SP 
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cm
–1
), phosphate and sugars (1096–1016 cm
–1
). Bold labels refer essentially to lipid bands. (h) FTIR spectra normalized to 
the maximum of NH stretching and amide I bands for the regions at high and low wavenumbers, respectively. Note that no 
baseline correction was applied to the spectra. (i) Arrow indicates the spectral change, i.e. a decrease in intermolecular β-
sheet structures, going from the core to the periphery of the plaque, corresponding to the black dots in (k). 
 
Protein distribution images (figure 1d–f) show the prevalence of Aβ plaques identified as red spots in 
this region. Red in the pseudo-colour images corresponds to high absorbance hence high 
concentration of the molecular species, whilst blue corresponds to low absorbance hence low 
concentration. Figure 1f is an image based on the amide I sub-peak at 1628 cm–1, which is distinctive 
for intermolecular β-sheet structures 18. Images of the lipids (figure 1b,c), based on the ester 
carbonyl stretching ( ν(C=O)ester ) at 1735 cm
–1
 and CH stretching ( ν(CH) ) in the range 3003–2805 
cm
–1
 obtained from the same measurement, show lipids as green regions mostly co-localized with 
the plaques. The blue arc in figure 1b denotes the Stratum Pyramidale (SP), which is the cell body 
layer, where lipids are less abundant. Stratum Oriens (SO), Stratum Radiatum (SR) and Stratum 
Lacunosum Moleculare (SLM), all containing non-myelinated components such as axonic and 
dendritic processes (from CA1 pyramidal neurons, apical and basal dendrites, and other CA1 inter-
neuronal processes) and sparse cell bodies, have intermediate lipid content and are shown as cyan. 
The red arc in figure 1b,c identifies a layer that corresponds to the alveus, containing myelinated 
axons (myelin electrically insulates axons and speeds neural conduction) projecting from the CA1 
subfield of the hippocampus to other brain areas. 
 
The distinctive structure of Aβ deposits is clearly visualized in figures 1k,l, which present the dense 
core plaque identified by the crosshair cursor in figure 1j. The distributions of the protein and lipid 
ester bands show a dense core that is rich in polypeptides (figure 1k) and a ring-shaped region 
around the core rich in lipids (figure 1l). Spectra selected from different regions of the plaque show 
(figure 1g) a gradient of absorbance, which decreases from the core through to the periphery due to 
a decrease in thickness of the tissue section and/or in tissue density. The corresponding normalized 
spectra (figure 1h) show relevant differences between profiles: the plaque core spectrum (red line) 
has a doublet bandshape for the amide I mode, with a maximum at 1651 cm–1, generally assigned to 
α-helix, and a shoulder at 1628 cm–1, associated with β-sheet 10; conversely, the periphery of the 
plaque has a single broad band at 1654 cm
–1
. The observed spectral change indicates a gradual 
decrease of protein signals due to the intermolecular β-sheets (at 1628 cm
–1
), amide II (figure 1i) and 
the amyloid band (plausibly due to CH deformation, at 1404 cm
–1
 
12
) accompanied by an increase of 
lipid bands (CH stretching at 2923 and 2852 cm–1, which are due to the asymmetric and symmetric 
stretching vibrations of lipid acyl CH2 groups, respectively; ν(C=O)ester at 1738 cm
–1) when going from 
the core through to the periphery of the plaque. To analyse these variations, difference spectra were 
calculated (see below). Figure 1 shows representative images of FTIR-visualised plaques - more 
samples from different mice and more sections from the same mice can be found in the 
Supplementary Information (figure SI-1). 
 
To confirm that the plaques identified with µFTIR imaging were indeed genuine plaques, we 
compared the FTIR images directly with immunofluorescence imaging based on amylo-glo staining of 
the same specimen (see figure 2). Amylo-glo fluorescence assay is a consolidated “gold standard” for 
the detection and quantification of Aβ 19. Figure 2d shows an overlay between the FTIR image 
(rainbow) and the amylo-glo staining (white). 
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 Figure 2. Visible, µFTIR and fluorescence images of a section of transgenic mouse brain containing the hippocampus. (a) 
Photomicrograph; dense core plaques appear darker than surrounding tissue. The box (black) indicates an area where a 
fluorescence image was obtained. (b) FTIR image showing the distribution of the integrated absorbance of the 
intermolecular β-sheet structures in the range 1645–1622 cm
–1
 (baseline at 1716–1595 cm
–1
). (c) Fluorescence image of 
the section stained with amylo-glo for Aβ peptide. (d) Composite image formed by overlaying the FTIR and fluorescence 
(white pixels) images. 
 
The hippocampi of wild type (WT) mice entirely lack plaque pathology. µFTIR imaging applied to ex-
vivo hippocampal sections from WT mice (figure SI-2) reveal no occurrence of the plaque structures 
observed in TG animals. The distributions of intermolecular β-sheet (figure SI-2a,d) do not present 
the focal accumulations representative of plaques observed in the TG mice brain (see e.g. figure 1f). 
Similarly, the lipid distributions (figure SI-2b,e) show no appearance of ring-shaped regions, but 
instead simply outline the normal layered anatomical structure of the hippocampus. Staining with 
the amyloid-specific probe amylo-glo did not reveal the presence of any plaque in these samples 
(figure SI-2c,f). 
 
Correlative FTIR imaging and Raman mapping. Combining Raman and infrared imaging is a powerful 
tool as FTIR can rapidly scan large fields of view so that images of plaques can be made, while Raman 
microscopy has higher spatial resolution (diffraction limited to λ/2NA = 0.8 µm) but, in general, is a 
much slower technique restricting the number of plaques that can be analysed. To our knowledge, 
this is the first time that a side-by-side comparison of Raman with µFTIR has been performed on 
individual plaques.  
 
Correlative µFTIR imaging, Raman mapping and fluorescence imaging were conducted on TG and WT 
mice brain specimens. Raman microscopy revealed the presence of β-pleated sheet conformation in 
the plaque core and the lipid ring around it, as shown in figure 3. 
 
(a) 
(b) 
(c) (d) 
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Figure 3. (Top and middle panels) Photomicrographs, µFTIR images and Raman principal component analysis (PCA) score 
maps of a transgenic mouse brain hippocampal section. Black box in (a) indicates a specific plaque area within the whole 
tissue FTIR image. The FTIR images refer to the distribution of the integrated absorbance of the (b) amide II (1588–1482 
cm
–1
) and (c) lipid ν(C=O)ester band (1761–1722 cm
–1
), and of the height of the β-sheet peak (at 1628 cm
–1
). Colour scale 
limits are (b) 15 to –1.5, (c) 1.5 to 0.5, and (d) 0.9 to –0.09. Black box in (e) denotes a 99⨉99 µm
2
 area (same plaque as in a) 
where a Raman map was acquired using a 1.4 µm step-size. Map scores were derived from PCA applied to the Raman map 
and refer to the distribution of (f) average spectrum, (g) lipid-rich envelope and (h) β-sheet protein core(s) of the plaque. 
(Bottom panel) Representative FTIR spectra and Raman loading plots of a plaque. (i) Spectra extracted from a µFTIR image 
(figure 1k) and normalized with respect to the amide I band peak absorbance. Amide I peak position is 1651 cm
–1
 for the 
core and 1654 cm
–1
 for the ring, indicative of protein’s α-helix conformation; the core spectrum has a doublet bandshape 
for the amide I mode. A difference spectrum was obtained by subtracting the ring profile from the core profile; it shows a 
loss of absorbance for the core spectrum at ca. 1738 cm
–1
 (lipid esters) and a gain at 1628 cm
–1
 (intermolecular β-sheets) 
and 1404 cm
–1
 (not fully clarified signature of the plaque core, slightly shifted to the position found in a different mouse 
model 
12
). (j) Loading plots extracted from PCA applied to the Raman map (in the middle panel). PC3 corresponds to the 
core spectrum and presents the distinctive amide I symmetric peak of the β-sheet conformation at 1667 cm
–1
, 
15
 whilst PC2 
represents the ring, with resonances due to lipids (distinctive bands at 1434 (CH2 deformation) and 1123 cm
–1
 (C–C 
stretching) ) and other protein conformations (1648 cm
–1
, assigned to α-helix and random coils) 
20
. PC1 denotes the mean 
spectrum of the tissue. 
 
(i) (j) 
(a) (c) (b) 
(e) 
(f) (g) (h) 
(d) 
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Figures 3a and e display a TG hippocampal section visualised under the FTIR microscope (15⨉ 
objective) and Raman microscope (20⨉), respectively; the latter photomicrograph shows the area 
where a Raman map of a plaque in CA1 was acquired. Figures 3b–d are portions of FTIR mosaic 
images of a plaque based on the protein (amide II), lipid ester and β-sheet peak (height) distribution, 
respectively. PCA was applied to the Raman map (72⨉72 points at 1.4 µm distance) and the first 
three components were analysed. PC1, which represents the average spectrum of the sample, is 
shown in figure 3f, whilst figures 3g,h are score maps of PC2 and PC3, respectively, which give the 
distribution of the lipid ring surrounding the plaque core and the  β-pleated sheet protein 
conformation – mainly concentrated in the core. From these images it is apparent that the higher 
spatial resolution of Raman microscopy enables a detailed analysis of the plaque structure, as shown 
in figure 3f–h. Multivariate analysis applied to all Raman datasets aided in extracting the relevant 
information that otherwise was hard to disentangle through a univariate spectral analysis. 
These results show that (1) Raman can reveal the same structures as can be seen with FTIR imaging 
(i.e. protein rich core and lipid ring), while also showing additional features such as cell bodies (figure 
4b – more discussion on this follows); (2) Raman has better resolution than FTIR and can reveal 
similar chemical structures; it is also much slower and cannot be easily applied to a large field of 
view, which is an advantage of using FTIR. 
Figure 3i illustrates representative µFTIR spectra of a plaque in a TG mouse brain sample. The 
spectrum of the core presents the weakest absorbance of the lipid band (C=O stretching at 1738 cm
–
1), indicating a lower lipid concentration in the core than in the ring around the plaque, in 
accordance with previous observations 21. A change in bandshape of the amide I band is clearly 
revealed here, the core spectrum showing a maximum at 1651 cm
–1
, which is shifted at 1654 cm
–1
 in 
the ring spectrum. This spectral effect may be attributed to a change in the secondary structure of 
the proteins in the two sub-regions of the plaque. At these high frequencies, absorption due to the 
α-helix conformation is expected 10; a lower wavenumber position of the amide I band maximum in 
the core profile correlates with an increase of (β-sheet) ordered structure for the proteins in the 
plaque core area, while less ordered peptide structures would characterize the ring. Such an effect 
has been previously reported for both the Aβ peptide 
21
 and other proteins 
22, 23
. Here the 
enhancement of absorbance at 1628 cm
–1
 (ordered conformation), highlighted by the difference 
spectrum in figure 3i, can be referred to the peptide’s intermolecular β-sheet structures which are 
characteristic of the core. 
Figure 3j is a plot of the three PCs’ loadings derived from PCA applied to the Raman map of a plaque 
(figure 3e–h). The plots are labelled based on the structures they represent: PC1-mean spectrum of 
the tissue, PC2-ring, and PC3-core. The main resonances in these plots are also reported. Notable 
differences characterize the amide I region, with the core exhibiting a symmetric intense peak at 
1667 cm–1 due to β-pleated sheet 15, and the ring showing signatures of lipids and other protein 
conformations, e.g. α-helix 20. 
 
Cellular and functional correlates. To elucidate the origin of the lipid ring around the amyloid plaque 
core detected by FTIR imaging and Raman microscopy, we performed a second subset of 
experiments using amylo-glo and immunofluorescent co-labelling with antibodies for astroglia 
(GFAP). These cell types have previously been reported to cluster around plaques 
24-28
. 
 
To establish if there was a link between the astrocyte processes and the lipid ring, we compared the 
ratio of the diameter of the plaque core to the width of the lipid ring for a number of plaques in both 
the immunofluorescent, µFTIR and Raman images. An example of this measurement can be seen in 
Figure 4, with a Raman image of a plaque alongside an immunofluorescence image. Using the ratio 
of plaque core to lipid ring provided a robust relative measure that could be used on a number of 
different sized plaques, in different samples. We obtained a ratio of 0.45 ± 0.05 (N=30 plaques) for 
all plaques visualised by µFTIR, Raman and immunofluorescence. As the lipid ring has approximately 
the same width as the astrocyte processes, and they co-localise in the same position about the 
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plaque core, we conclude that this is compelling evidence that the lipid ring is associated with the 
astrocyte processes. 
 
More examples of immunostained plaques can be seen (figure SI-4) which reveal that astrocytes 
cluster around the vast majority of the plaques and have cell bodies located in the outer rim of the 
cluster while radially projecting processes (i.e. membrane extensions) towards the plaque core. This 
is a feature of astrogliosis in the brain parenchyma. 
 
Interestingly, we also show how Raman has the spatial resolution to detect cell bodies. In figure SI-
3c, the Raman map shows cell bodies in the region surrounding the lipid-rich halo of the plaque that 
are revealed as small ovoids of ca. 10 µm diameter (yellow in the pseudo-colour map). The presence 
of nearby cell bodies has previously been revealed by synchrotron-based µFTIR imaging but not by 
globar source µFTIR 12, suggesting that high spatial resolution is a requirement for (unlabelled) 
detection of these small features. The Raman maps presented here give high definition for the cell 
bodies and comparable spatial resolution to the synchrotron FTIR images. Similar cell bodies can also 
be seen in immunofluorescent images (figure 4d). 
 
 
Figure 4. (Top panel) Self-organising map principal component analysis (SOM PCA) results derived from a Raman map of a 
plaque in a transgenic mouse brain hippocampal section. The Raman map was acquired over a 92⨉92 µm
2
 area using a 1.4 
µm step-size. Map scores refer to the distribution of the (a) SOM PC1, which denotes the β-sheet core of the plaque, and 
(b) SOM PC2, showing the lipid halo surrounding the plaque core. Corresponding loading plots are shown in figure SI-3. 
(Bottom panel) Immunofluorescence images at 20⨉ magnification of a large plaque within a section of TG mice brain 
containing the hippocampus stained with (c) amylo-glo for Aβ peptide and (d) GFAP for astroglia. The plaque represented 
in a) and b) is different from the one in c) and d). Arrows indicate the location of processes and cell bodies. Segments 
denote the size of the plaque core and lipid ring, providing a measure of the lipid ring width-to-plaque core diameter of 
approximately 0.5 in both types of images. 
 
 
(a) (b) 
(c) (d) 
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Discussion 
 
The chemical structure and formation of amyloid plaques is a much studied, but still controversial 
topic. Here we have used spectroscopic tools to chemically analyse plaques in situ, in combination 
with conventional fluorescence stains to visualise plaques and surrounding biological processes. Our 
results are consistent with the hypothesis that a lipid-ring, which is seen surrounding many plaques, 
is associated with astrocyte processes. This is evidenced by immunohistochemistry images that show 
astrocyte processes surrounding plaques (stained with amylo-glo) and co-localising with the lipid 
ring. 
 
µFTIR imaging and Raman micro-spectroscopy were applied to study the chemical composition of Aβ 
plaques in the hippocampal CA1 region of the brain of TASTPM mice, an Aβ-overexpressing 
transgenic mouse line. Previous studies have used µFTIR imaging for the visualization of amyloid 
plaques and have found lipid rings surrounding some plaques 
21, 29
. However, this is the first time 
that both FTIR imaging and Raman microscopy were applied through a site-matched approach in 
order to fully describe the structure and composition of these plaques. We observed changes in 
plaque composition between the core and the periphery (ring, or shell if considered in 3-D). The core 
appeared to be richer in ordered (intermolecular β-pleated sheet) structures, the concentration of 
which tends to progressively decrease from the core through to the periphery of the plaque; on the 
other hand, lipids appeared to be less concentrated in the core of the plaque, instead forming a ring-
shaped distribution co-localized with less ordered protein structures. The progressive reduction of β-
pleated sheet structures from the core to the periphery of the plaque was confirmed through Raman 
maps (with NIR 830 nm excitation). 
 
Fluorescent labelling for Aβ peptide and astrocytes confirmed that some plaques are clustered with 
astrocytes; this is paralleled by the observation that some plaques have a lipid-rich layer around the 
core (detected by FTIR imaging and Raman mapping). Raman maps elucidate the finer details of the 
plaque structure, revealing small ovoids in the outer rim of the plaque that correspond to the cell 
bodies of astrocytes. Astrocytic processes radially extend from the cell bodies towards the core of 
the plaque, co-localizing with the lipid-loaded ring. As for equal volumes the surface/volume ratio 
(approximately corresponding to the lipid/water ratio in cells) is higher in elongated processes 
compared to ovoids, we infer that the astrocytic processes surrounding the plaques likely 
correspond to the origin of the lipid signal detected in this region. This is an important observation, 
as it reveals that the ring around the plaque can itself be a marker of astrogliosis. It should be 
highlighted that the lipid signal may also originate from the activated microglia surrounding Aβ 
plaques 30; however, astrocytes are more likely, as activated microglia are less ramified compared to 
non-activated microglia 31, 32. 
 
As with microglia activation, astrogliosis is strongly associated with amyloidopathy. Several lines of 
evidence suggest that while the amyloid-dependent microglial activation is responsible for increased 
risk and more severe progression of AD 
30, 33
, amyloid plaque-associated astrogliosis is negatively 
correlated to AD development 
24
. Post-mortem studies of the brain of people with Alzheimer’s 
disease and non-demented age-matched controls have shown that amyloid plaques can also be 
found in the brain of non-demented controls, especially older people 34, 35, suggesting that other 
factors might promote the pathogenesis and progression of the disease. Also, a recent study has 
shown that patients with lower mini mental state exam (MMSE) scores have a lower astrogliosis-
associated plaque burden, suggesting that astrogliosis might have a protective role limiting the 
development of amyloidosis-dependent dementia 
24
. 
 
The ability of µFTIR imaging and Raman microscopy to detect both Aβ plaques and plaque-
associated astrogliosis might allow the use of chemical imaging to identify astrogliosis and clustered 
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inflammation in nerve tissue with amyloidosis, with potential for translation into an early diagnostic 
tool. The biochemical information this brings will likely prove invaluable for further elucidating the 
mechanisms of AD. 
 
 
Conclusions 
 
In this paper, we have focussed on analysing the chemical composition of plaques in a transgenic 
mouse model of Alzheimer’s disease, using µFTIR imaging and Raman microscopy, with correlative 
immunofluorescence imaging. We have found that the plaques tend to have a protein-rich core, high 
in intermolecular β-sheets, surrounded by a lipid ring. This ring correlates with processes from 
astrocytes (and possibly microglial cells), which we propose are the origin of the lipid-rich ring found 
in µFTIR images and Raman maps. This is a novel finding and adds weight to the hypothesis that 
plaques cause chronic inflammatory responses to the surrounding tissue, which could potentially be 
a root cause of neurodegeneration. 
 
 
Methods 
 
Animal procedures. Animal procedures complied with the UK Home Office Guidelines and the 
University of Exeter Animal Welfare Ethical Review Board. Male 12 months old Aβ-overexpressing 
TASTPM (transgenic, TG) mice and age-matched littermate controls (wild type, WT) were used in this 
study. TASTPM mice carry two mutations on the gene for the amyloid precursor protein (APPSwe 
K670N, M671L) and one on the presenilin 1 gene (M146V) that can be found in patients affected by 
familial Alzheimer’s disease 
16, 17
. All animals were housed at room temperature under a 12 hour light 
cycle, and fed a normal diet with free access to food and water ad libitum before being sacrificed 
36
. 
 
Tissue collection and sectioning. The animals were humanely sacrificed by cervical dislocation 
(Schedule 1, ASPA, 1986). The brain was rapidly removed and acute horizontal slices of 300 μm 
thickness were cut in a vibratome and suspended in artificial cerebrospinal fluid, as previously 
described 36. The major part of each brain was used for electrophysiological recordings. A number of 
slices of each brain (TASTPM and WT mice) containing ventral hippocampus, striatum and cortex 
were retained for the present study. The slices were post-fixed overnight with 4% formalin + 0.1 M 
phosphate buffer solution (PBS). They were rinsed twice (5 min each time) with 0.1 M PBS and 
stored in 30% (w/v) sucrose solution to inhibit subsequent formation of ice crystals, before being 
embedded in a water-soluble frozen section medium (NEG-50, Thermo Scientific) and snap frozen. 
Sections of 20 μm thickness were cut in a cryostat and left to rinse for at least 24 hours in 0.1 M PBS. 
Sections were subsequently rinsed in distilled water and mounted on Raman-grade polished calcium 
fluoride slides (Crystran, Poole, Dorset, UK). 
 
Microscopy and spectroscopy. Three brain sections per animal (five TASTPM and five WT mice) 
were analysed giving a total of 30 specimens. For two random sections, measurements were rerun 
to assess their repeatability. 
Micro-transmission Fourier transform infrared (µFTIR) images were collected with an imaging system 
consisting of an Agilent Technologies Cary 670 FTIR spectrometer coupled to a Cary 620 FTIR 
microscope with a 0.62 NA, 15⨉ Cassegrain objective, and a liquid nitrogen-cooled focal plane array 
(FPA) detector. The detector had 16384 pixels arranged in a 128⨉128 array. The area imaged in 
µtransmission mode through the 15⨉ objective corresponds to 704⨉704 µm
2
. Characteristic bands 
of proteins and lipids, principally amide I, amide II, ester carbonyl and CH stretching, were analysed, 
yielding images with a spatial resolution in the range of 5–10 µm (fingerprint region). These bands 
constitute the spectral signatures of the main components of amyloid plaques.11 Resolutions Pro v. 
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5.3 software was used for acquisition and manipulation of the data. An IR absorption spectrum was 
obtained for each detector pixel by co-adding 32 interferograms and applying a Fourier transform. 
The Blackmann-Harris 4-point apodization function was used. Spectra were measured over the range 
4000–1000 cm
–1
 at a spectral resolution of 4 cm
–1
 with a zero filling factor of 2, achieving a spectral 
spacing of approximately 2 cm–1. Prior to all image measurements, a background obtained from a 
tissue-free region of the substrate was measured by co-adding 64 interferograms. Large images of 
the whole hippocampus were constructed as mosaics of individual tiles; each tile was selected to be 
128⨉128 pixels. 
FTIR imaging data are hyperspectral datasets, with two spatial dimensions and a third spectral 
dimension (wavenumber); each value in the datasets is absorbance of the sample at each 
combination of position and wavenumber. Absorbance is related to concentration of a chemical 
constituent through the Beer-Lambert law, thus enabling label-free compositional analysis. In the 
present work, the whole mid-infrared spectrum between 4000 and 1000 cm–1, containing the 
absorption bands of proteins and lipids, was measured for each detector pixel. To calculate the 
absorbance of each band, a linear baseline was drawn between the minima either side of the peak 
and absorbance values above this line were integrated with respect to wavenumber. This enabled 
chemical images to be obtained (univariate analysis). 
Raman micro-spectroscopy maps were collected with a Renishaw inVia Raman microscope equipped 
with an 830 nm laser and a Leica long working distance 50⨉ (NA 0.50) objective. The backscattered 
light from the sample was dispersed through a 600 gr/mm grating onto a Renishaw deep depletion 
CCD camera. The spectral resolution was approximately 7 cm
–1
. Raman maps were acquired in 
streamline mode with an exposure time of 55 s per laser line (equivalent to ca. 9 s per point) with 
step size of 1.4 µm, in the range 2400–450 cm
–1
. WiRE v. 4.0 software was used for acquisition and 
manipulation of the data. Accurate calibration of the set-up and focus adjustment of the objective 
was performed before each series of measurements. Spectra were collected with the focus position 
8 µm into the specimen. Cosmic ray removal was applied to each spectrum using the nearest 
neighbour method. Spectral maps were then analysed by Principal Component Analysis (PCA) using 
10 components and spectrum centring + normalization (SNV) pre-processing. In this manner, the 
first principal component (PC1) corresponds to the average spectrum of the sample. Results were 
reported as obtained, without any further modification including baseline correction. 
Alternatively, when analysing the Raman maps using SOMs the cosmic rays were removed by the 
following method: cosmic rays were filtered from the Raman maps by applying a 3×3 window two-
dimensional median filter to each wavenumber. For the 3×3 window used, the centre pixel for that 
wavenumber is replaced with the median value of all pixels in the window for that wavenumber. 
After the application of median filtering to each wavenumber, the collected Raman spectra were 
unfolded to create a large, two-dimensional data matrix where each row corresponds to the Raman 
spectrum of a single pixel and each column to a single wavenumber. At this stage the spectra were 
compressed using the Self Organising Maps (SOM) algorithm (as described in ref 
37
), followed by 
extended multiplicative scatter correction, mean centring and then PCA. 
The tissue samples analysed by µFTIR imaging and Raman microscopy were subsequently stained 
with amylo-glo reagent (Biosensis), mounted with fluoromount (Sigma) and imaged on a Nikon 
Eclipse EF-800 epifluorescence microscope. Staining was performed as previously reported 
19
; see 
also the Supplementary Information for a detailed description of amylo-glo staining of Aβ plaques. 
To clarify the origin of the lipid signature in the region surrounding the plaque core in µFTIR images 
of TASTPM mouse hippocampus, slices were immunohistochemically stained for astroglia and co-
stained with amylo-glo to check the pattern of distribution of astrocytes with respect to the Aβ 
plaque cores. See SI for a detailed description of the immunohistochemical procedures. All images 
were taken with an epifluorescence microscope. 
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